Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : SRNE save search
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
Published: 2021-01-27 (Crawled : 01:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 3.07%
H: 58.57%
C: 41.81%
covid positive results treatment phase 1b phase 2b
Sorrento Therapeutics Announces Positive Phase 2a Clinical Trial Results for Resiniferatoxin (RTX) for the Treatment of Knee Pain in Moderate to Severe Osteoarthritis of the Knee (OAK) Patients
Published: 2023-09-07 (Crawled : 13:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.52%
H: 42.58%
C: 36.03%
osteoarthritis positive treatment trial therapeutics results
Dyadic and Sorrento Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Published: 2021-08-11 (Crawled : 13:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.0%
H: 1.36%
C: 0.68%
DYAI 4 | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: 20.33%
H: 28.7%
C: 22.22%
covid vaccine license technology
Sorrento and Dyadic Announce Binding Term Sheet to License Dyadic’s Lead COVID-19 Vaccine Candidate “DYAI-100” and C1 Technology for Protein-Based Coronavirus Vaccines and Therapeutics
Published: 2021-08-11 (Crawled : 13:15) - biospace.com/
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.0%
H: 1.36%
C: 0.68%
DYAI 4 | $1.5 -1.96% -2.0% 8.8K
|
Health Technology
|
| O: 20.33%
H: 28.7%
C: 22.22%
covid vaccine license technology
Sorrento Therapeutics, Inc.'s Bankruptcy Court Orders Brokerage Firms to Credit Dividended Scilex Stock to Customers' Accounts and Sorrento Advises Holders of Dividended Scilex Stock to Contact Brokerage Firms to Deliver the Stock to Individual Accounts
Published: 2023-05-14 (Crawled : 20:20) - prnewswire.com
SCLX | $0.984 3.43% 3.31% 550K
|
|
| O: 1.29%
H: 48.72%
C: 21.35%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 3.3%
H: 26.37%
C: 14.45%
Court Confirms Sorrento Therapeutics, Inc.'s $125 Million Arbitration Award Against NantPharma, LLC
Published: 2023-03-17 (Crawled : 15:00) - prnewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -0.96%
H: 29.96%
C: 17.63%
award
Joint Statement by Sorrento Therapeutics, Inc. and Scilex Holding Company on Today’s Isolated Chapter 11 Filing By Sorrento Therapeutics, Inc.
Published: 2023-02-13 (Crawled : 21:00) - globenewswire.com
SCLX | $0.984 3.43% 3.31% 550K
|
|
| O: 0.56%
H: 16.29%
C: 14.04%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -4.74%
H: 9.55%
C: -19.39%
Scilex Holding Company Provides Notice to All Lenders of Short Positions in the Restricted Dividend Shares of Scilex Holding Company
Published: 2023-10-04 (Crawled : 17:00) - globenewswire.com
SCLX | $0.984 3.43% 3.31% 550K
|
|
| O: -1.59%
H: 14.52%
C: 13.71%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -2.26%
H: 8.8%
C: 1.87%
company
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), Debuts on Nasdaq Under Ticker “SCLX”
Published: 2022-11-10 (Crawled : 20:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -0.62%
H: 17.39%
C: 13.66%
nasdaq
Scilex Holding Company, a majority-owned subsidiary of Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”), and Vickers Vantage Corp. I Announce the Closing of their Previously Announced Business Combination
Published: 2022-11-10 (Crawled : 20:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -0.62%
H: 17.39%
C: 13.66%
Sorrento Therapeutics to Participate in Morgan Stanley 20th Annual Global Healthcare Conference September 12-14
Published: 2022-09-08 (Crawled : 14:00) - biospace.com/
MS | News 0 d | $93.76 1.81% 0.12% 6.4M
|
Finance
|
| O: -0.38%
H: 2.27%
C: 2.21%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: -1.88%
H: 14.35%
C: 13.4%
global conference therapeutics
Sorrento Announces Positive Preliminary Results of Phase 1b Study of COVI-MSC™ for Treatment of ICU COVID-19 Patients
Published: 2021-01-26 (Crawled : 01:00) - biospace.com/
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.65%
H: 14.78%
C: 11.56%
covid positive results treatment phase 1b phase 2b
Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test for the Detection of SARS-CoV-2 Viral Antigen
Published: 2020-12-22 (Crawled : 00:02) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 6.51%
H: 15.47%
C: 11.31%
fda merge test authorized sars-cov-2 application emergency use authorization
Sorrento Receives Orders of COVISTIX for Commercial Launch in Brazil
Published: 2021-12-06 (Crawled : 20:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
order brazil commercialization
Sorrento Therapeutics’ Clinical Laboratory Receives Accreditation From the College of American Pathologists
Published: 2021-12-07 (Crawled : 19:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
therapeutics
Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July
Published: 2021-06-24 (Crawled : 18:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.44%
H: 11.34%
C: 10.13%
covid test license approval authorized
Scilex Holding Company’s Wholly Owned Subsidiary, Scilex Pharmaceuticals Inc., Enters into a Term Sheet with Virpax Pharmaceuticals, Inc. Regarding a Mutual Release and Settlement Agreement
Published: 2024-02-26 (Crawled : 22:00) - globenewswire.com
SCLX | $0.984 3.43% 3.31% 550K
|
|
| O: 1.45%
H: 15.24%
C: 10.0%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 7.14%
H: 66.67%
C: -11.0%
virpax wholly pharmaceuticals agreement
Sorrento Successfully Completes Phase 1 Study and Is Proceeding to Implement Global Registrational Trials with STI-1558, an Oral Mpro Inhibitor as a Standalone Oral Treatment and Prevention of COVID-19 without the Need for a Ritonavir Booster
Published: 2022-10-17 (Crawled : 13:00) - globenewswire.com
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 4.48%
H: 11.43%
C: 9.29%
sti-1558 covid-19 treatment trials global study
Scilex Holding Company Added to the Preliminary List of the Russell 3000® Index and the Small-Cap Russell 2000® Index as part of the 2023 Russell Indexes Annual Reconstitution in June 2023
Published: 2023-05-22 (Crawled : 13:00) - globenewswire.com
SCLX | $0.984 3.43% 3.31% 550K
|
|
| O: 0.84%
H: 14.24%
C: 8.89%
LDNXF | $115.907 -12.32% 870
|
Finance
|
| O: -1.28%
H: 1.76%
C: 0.29%
LNSTY | $28.6 0.53% 130K
|
Finance and Insurance
|
| O: 0.26%
H: 0.3%
C: 0.09%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 0.03%
H: 11.08%
C: 9.35%
3000 index
Anxious World Waits As Covid Vaccine Makers Address Omicron Variant
Published: 2021-12-07 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 5.22%
H: 0.0%
C: -1.25%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: 2.13%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 0.14%
H: 0.0%
C: 0.0%
VIR | $8.13 0.37% 0.37% 770K
|
Health Technology
|
| O: -6.42%
H: 8.6%
C: 8.45%
SRNE | $0.015 -8.85% 140K
|
Health Technology
|
| O: 6.57%
H: 14.77%
C: 11.21%
RDHL | $0.4277 -3.32% -3.44% 470K
|
Health Technology
|
| O: 0.37%
H: 10.37%
C: 9.63%
covid vaccine
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.